Table 4.
Sensititvity analysis: mean costs/ cost differences depending on management of local relapse, given in € (2015)
| IMRT | IMRT + C12 | difference | |
|---|---|---|---|
| mean total costs (€) | |||
| re-RT always as IMRT | |||
| mean unadjusted | 15,078.- | 29,636.- | 14,558.- |
| mean adjusted (3 monthly intervals) | 15,204.- | 31,859.- | 16,655.- |
| mean adjusted annually | 12,066.- | 30,108.- | 18,042.- |
| mean adjusted, 3.5% discount | 11,635.- | 28,558.- | 16,923.- |
| mean adjusted 3.0% discount | 11,694.- | 28,758.- | 17,065.- |
| mean total costs (€) | |||
| re-RT always as C12 | |||
| mean unadjusted | 24,570.- | 36,554.- | 11,984.- |
| mean adjusted (3 monthly intervals) | 25,058.- | 41,745.- | 16,687.- |
| mean adjusted annually | 18,707.- | 39,272.- | 20,565.- |
| mean adjusted, 3.5% discount | 17,810.- | 36,050.- | 18,240.- |
| mean adjusted 3.0% discount | 17,931.- | 36,459.- | 18,528.- |